HSBC Holdings
HARP

HSBC Holdings’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

HSBC Holdings’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,033
Closed -$165K – 3226
2020
Q4 		$165K Buy
1,033
+26
+3% +$4.02K ﹤0.01% 2866
2020
Q3 		$170K Hold
1,007
– – ﹤0.01% 2513
2020
Q2 		$167K Hold
1,007
– – ﹤0.01% 2415
2020
Q1 		$117K Buy
+1,007
New +$142K ﹤0.01% 2444

Other funds holding HARP

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

HSBC Holdings's HARP Position: Q1 2021 in Review

HSBC Holdings sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q1 2021, closing a stake of 1,033 shares — an estimated $165K sold.

HSBC Holdings first reported a position in HARP in Q1 2020 and held it in 4 quarters. The position peaked at $170K in Q3 2020. 88 funds tracked by Wall St. Rank hold HARP as of Q1 2021.

  • HSBC Holdings reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • HSBC Holdings sold 1,033 Harpoon Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $165K.
  • HSBC Holdings first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q1 2020 and held it in 4 quarters.
  • HSBC Holdings's Harpoon Therapeutics, Inc. Common Stock position peaked at $170K in Q3 2020.
  • 88 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q1 2021.

Based on HSBC Holdings's 13F filing for Q1 2021, filed 14 May 2021.